Three patients with inadvertently positioned left heart pacemaker lead
s were admitted for neurological symptoms consistent with embolic stro
ke. In one of them, the pacemaker lead crossed the interatrial septum,
the mitral valve, and entered the left ventricle. in another it wets
erroneously placed through the subclavian artery, across the aortic va
lve, and into the left ventricular chamber. In the third patient, the
right ventricular lead of a DDD pacemaker was placed in the coronary s
inus and the right atrial lead crossed the interatrial septum, and int
ermittently entered the left ventricular cavity. Once anticoagulation
was initiated, symptoms resolved; they recurred when the level of anti
coagulation dropped leading to a major stroke in one of the patients.
Two of the patients were on aspirin at the onset of symptoms. We belie
ve that every approach must be considered to remove the malpositioned
lead. Otherwise, full dose anticoagulation must be initiated since ant
iplatelet therapy alone does not confer adequate protection against st
roke.